TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Bio Forte AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
14,061
|
14,113
|
14,752 |
Financial expenses |
8
|
7
![]() |
7 |
Earnings before taxes |
492
|
395
|
934 |
Total assets |
4,647
|
4,311
|
4,066 |
Current assets |
4,314
|
3,804
|
3,826 |
Current liabilities |
1,282
|
1,325
|
1,385 |
Equity capital |
3,365
|
2,981
|
2,674 |
- share capital |
200
![]() |
200
![]() |
200 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.4%
|
69.1%
|
65.8% |
Turnover per employee | |||
Profit as a percentage of turnover |
3.5%
|
2.8%
|
6.3% |
Return on assets (ROA) |
10.8%
|
9.3%
|
23.1% |
Current ratio |
336.5%
|
287.1%
|
276.2% |
Return on equity (ROE) |
14.6%
|
13.3%
|
34.9% |
Change turnover |
-52
|
-639
|
-1,668 |
Change turnover % |
0%
|
-4%
|
-10% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.